Accessibility Menu
PetIQ logo

PetIQ(NASDAQ) PETQ

This security has been delisted. This page is retained for historical reference.

PetIQ last closing stock price
MetricPriceDate
Last closeUSD 30.982024-10-24
PetIQ stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.23%USD 30.912024-10-17
1 month+0.72%USD 30.762024-09-24
3 month+41.53%USD 21.892024-07-26
Year to date+56.86%USD 19.752023-12-29
1 year+64.96%USD 18.782023-10-25
3 year+24.52%USD 24.882021-10-25
5 year+25.48%USD 24.692019-10-25
Since inception+32.85%USD 23.322017-07-21

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

PETQ Financials

Key Financial Metrics (TTM)

Gross Margin

22.94%

Operating Margin

5.45%

Net Income Margin

0.19%

Return on Equity

0.99%

Return on Capital

8.61%

Return on Assets

0.25%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$279.43M

Operating Income

$65.11M

EBITDA

$93.14M

Operating Cash Flow

$20.22M

Capital Expenditure

-$8.24M

Free Cash Flow

$11.98M

Cash & ST Invst.

$84.13M

Total Debt

$453.64M

PetIQ Performance Analysis

PetIQ annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 932,528,000N/A
20222022-12-31USD 921,513,000-1.2%
20232023-12-31USD 1,101,963,00019.6%
PetIQ sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30-11.9%
Q42023-12-31-20.6%
Q12024-03-3140.2%
Q22024-06-306.6%
PetIQ annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.57N/A
20222022-12-31USD -1.65192.4%
20232023-12-31USD 0.07N/A
PetIQ sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30-95.3%
Q42023-12-31-4047.4%
Q12024-03-31171.7%
Q22024-06-302.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$328.94M

+4.6%

Gross Profit

$88.28M

+19.5%

Gross Margin

26.84%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1,121

N/A

Net Income

$15.32M

+61.8%

EBITDA

$35.46M

+21.4%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$84.13M

+7.3%

Total Debt

$453.64M

-2.6%

Accounts Receivable

$214.98M

+11.1%

Inventory

$164.97M

+16.5%

Long Term Debt

$447.80M

-0.8%

Short Term Debt

$5.84M

-61.7%

Return on Assets

0.25%

N/A

Return on Invested Capital

8.84%

N/A

Free Cash Flow

$56.21M

+1.3%

Operating Cash Flow

$57.88M

+0.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALBOAlbireo Pharma, Inc.
$44.15+0.00%
PSTXPoseida Therapeutics, Inc.
$9.50+0.00%
ATRIAtrion Corporation
$459.92+0.06%
HARPHarpoon Therapeutics, Inc.
$23.01+0.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$159.65+0.27%
NOKNokia
$9.90+0.06%
AMIXAutonomix Medical
$8.59+1.35%
INTCIntel
$99.45+0.09%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.